King Charles III Diagnosed with Cancer, Reducing Public Duties for Treatment

  • 6 months ago
King Charles III has been diagnosed with cancer and will reduce his public duties while undergoing treatment. The cancer was detected during tests after Charles had a corrective procedure for an enlarged prostate last month.
Transcript
00:00 It's Benzinga and here's what's on the block.
00:02 King Charles III has been diagnosed with cancer and will reduce his public duties while undergoing
00:06 treatment. The cancer was detected during tests after Charles had a corrected procedure for an
00:10 enlarged prostate last month. Charles spent three nights in a London hospital last week where the
00:14 cancer tests were conducted. If Charles becomes too ill, some duties could be delegated to
00:18 councillors of state like Camilla and William. The diagnosis comes at a challenging time for
00:22 the royal family after recent health issues. It's unclear how long Charles's treatment will last,
00:27 but he remains positive about returning to duties.
00:29 For all things money, visit Benzinga.com
00:31 [BLANK_AUDIO]

Recommended

0:39
I
Up next
Lululemon Misses Revenue Target for First Time in Two Years Amid Botched Launch. CEO Defends Brand's Strength
Benzinga
0:42
Nvidia May Invest $100 Million in OpenAI, Joining Apple and Microsoft. Massive Funding Round Could Value the AI Startup at Over $1 Billion.
Benzinga
0:40
Dell Sees 9% Revenue Boost as AI-Optimized Server Sales Surge. AI Server Backlog Hits $3.8 Billion Amid Revenue Growth
Benzinga
0:36
Ulta Beauty's Earnings Miss Expectations as Same-Store Sales Decline. CEO Dave Kimbell Attributes Defends Company's Engagement and Operations.
Benzinga
0:36
Monday Sets New Global Temperature Record, Breaking Previous High - on Sunday.
Benzinga
0:58
Charlie Munger Revealed What Was Left On His Bucket List Before He Died
Benzinga
0:29
Former First Lady Melania Trump Opens Up About Emotional Journey of Writing Her Memoir as It Climbs up Amazon's Best Sellers List Ahead of Release Date
Benzinga
1:33
Jim Cramer Admits Palantir CEO Alex Karp's 'Insanity Is Growing On Me' After Q4 Earnings Call: 'Narrative Is Compelling'
Benzinga
0:51
Cathie Wood's Ark Invest Snaps Up $5.3M In Beaten-Down Crowdstrike Shares, Dumps $3.7M Worth Of Tesla Stock Before Q2 Earnings
Benzinga
1:27
Jim Cramer Says Investors Should Check Share Count Before Buying A Stock: 'You Want A Management That Agrees With You'
Benzinga
1:04
Jim Cramer Likes Palantir, Recommends Pioneer Natural Resources: 'I Want You To Ka-Ching, Ka-Ching'
Benzinga
0:58
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report
Benzinga
0:33
What's Going On With Alibaba Stock On Wednesday?
Benzinga
0:43
Ozempic Weight Loss Drug Maker Is Making Money Hand Over Fist - And Just Raised Its Profit Forecast
Benzinga
0:37
Keurig Dr Pepper's Q2
Benzinga
1:04
Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
Benzinga
10:06
Trade Ideas With Scott Redler Chief Strategic Officer of T3 Live and T3 Trading Group
Benzinga
0:57
Roaring Kitty Claws Back: GameStop Stock Rises Briefly On Position Update From Keith Gill — What You Need To Know
Benzinga
0:54
The Market Did Something Thursday That Has Only Occurred 4 Times In History
Benzinga
1:07
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
Benzinga
2:43
Tech Stocks Get Hit On NFLX and TSLA Earnings
Benzinga
3:09
How Big Is A.I. Going To Be For Amazon? - $AMZN
Benzinga
1:45
Are Housing Stocks Pointing Towards A Recession? - $TOL
Benzinga
0:57
Jim Cramer Says It's 'Still Not Too Late' To Buy This Energy Stock
Benzinga
1:15
Cathie Wood's Ark Goes Chip-Stock Shopping Ahead Of AMD Earnings, Adds More Of Warren Buffett-Backed Chinese EV Play
Benzinga